View Author
respifinder assay assay respifinder virus sample probe tobramycin infection combination result ceftazidime fication therapy regimen cell culture detection analysis synergism ampli antibiotic concentration strain culture method t 0 h monotherapy reaction combination therapy microbiol netherland agents chemother combination therapy regimens dilution aeruginosa rhinoviru target adenoviru multiplex speci curve -field gel electrophoresis agent oligonucleotide patient electrophoresis model primers pseudomonas aeruginosa pseudomona table chemother farcinica system antimicrob experiment sensitivity identi speci ficity sequence nocardia identi fied aeruginosa cf 133 study aukc 0-24h t 24 h fluenza mlpa probe /liter preampli fication step primer monoplex length mlpa probes coronaviru resistance cor-oc control pharmacokinetic pathogen mixture
3 Most Recent Publications
|
RespiFinder: A new multiparameter test to differentially identify fifteen respiratory viruses
(Article)
Reijans, M. Dingemans, G. Simons, G. Klaassen, C.H. Meis, J.F. Keijdener, J. Mulders, B. Eadie, K. Leeuwen, W.B. van Belkum, A.F. van Horrevorts, A.M. |
2008-04-01
|
|
Molecular typing of a suspected cluster of Nocardia farcinica infections by use of randomly amplified polymorphic DNA, pulsed-field gel electrophoresis, and amplified fragment length polymorphism analyses
(Article)
Kalpoe, J.S. Templeton, K.E. Horrevorts, A.M. Endtz, H.P. Kuijper, E. Bernards, A.T. Klaassen, C.H. |
2007-12-01
|
|
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model
(Article)
Hollander, J.G. den Horrevorts, A.M. Goor, M.L. van Verbrugh, H.A. Mouton, J.W. |
1997-01-01
|
